Search research articles
Contact Us
Filters
Showing results (41-50 of 102) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
June 29, 2022
Peripheral blood CD3<sup>+</sup> T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies
Geoffrey Fell, Ashley E Rosko, Gregory A Abel, et al.
Leukemia & Lymphoma
|
May 27, 2011
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Andrew A Lane, Steven L McAfee, Joanne Kennedy, et al.
Blood
|
May 17, 2003
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression
Peter Westervelt, Andrew A Lane, Jessica L Pollock, et al.
Leukemia & Lymphoma
|
June 21, 2022
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
James A Davis, David A Rizzieri, Andrew A Lane, et al.
Stem Cell Reports
|
November 25, 2014
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
Dongjun Lee, Stephen M Sykes, Demetrios Kalaitzidis, et al.
Plos One
|
November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypes
Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Leukemia & Lymphoma
|
October 24, 2025
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Andrew A Lane, Cristina Papayannidis, Emanuele Angelucci, et al.
Cancer
|
January 5, 2026
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm
Marina Konopleva, Naveen Pemmaraju, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
March 11, 2025
Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial
Naveen Pemmaraju, Marina Konopleva, Kendra L Sweet, et al.
Blood Advances
|
March 18, 2020
Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm
Jason Nomburg, Susan Bullman, Sun Sook Chung, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 102) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
June 29, 2022
Peripheral blood CD3<sup>+</sup> T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies
Geoffrey Fell, Ashley E Rosko, Gregory A Abel, et al.
Leukemia & Lymphoma
|
May 27, 2011
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Andrew A Lane, Steven L McAfee, Joanne Kennedy, et al.
Blood
|
May 17, 2003
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression
Peter Westervelt, Andrew A Lane, Jessica L Pollock, et al.
Leukemia & Lymphoma
|
June 21, 2022
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
James A Davis, David A Rizzieri, Andrew A Lane, et al.
Stem Cell Reports
|
November 25, 2014
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
Dongjun Lee, Stephen M Sykes, Demetrios Kalaitzidis, et al.
Plos One
|
November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypes
Nobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Leukemia & Lymphoma
|
October 24, 2025
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Andrew A Lane, Cristina Papayannidis, Emanuele Angelucci, et al.
Cancer
|
January 5, 2026
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm
Marina Konopleva, Naveen Pemmaraju, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
March 11, 2025
Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial
Naveen Pemmaraju, Marina Konopleva, Kendra L Sweet, et al.
Blood Advances
|
March 18, 2020
Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm
Jason Nomburg, Susan Bullman, Sun Sook Chung, et al.
Page
of 11